MetroHealth CRS (2503)

Cleveland, Ohio 44109

0 studies enrolling now · 11 studies all time

What they study most

HIV Infections, HIV-1 Infection, HIV-1 and Hepatitis C Co-Infection

Studies at this site

• Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen — Completed
• FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir — Completed
• Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells — Completed
• Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression — Completed
• Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults — Completed
• Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance — Completed
• High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART — Completed
• Sevelamer for Reducing Endotoxemia and Immune Activation — Completed
• Rifaximin as a Modulator of Microbial Translocation and Immune Activation — Completed
• Chloroquine for Reducing Immune Activation in HIV- Infected Individuals — Completed
• Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults — Completed